logo
In vivo electrochemical measurements: past, present and future
The challenges of product- and process-related impurities to an evolving biopharmaceutical industry
7th Workshop on Recent Issues in Bioanalysis (WRIB) – where regulators and industry convene
Streamlined analysis of synthetic cannabis metabolites looks to provide quick and effective testing
Integrated bioanalytical services for biotherapeutics are expanded by Aptuit
PerkinElmer enters Chinese diagnostic market
Pharmaceutical companies to develop database on clinical trial sites
Conference Report: Chemistry: a bridge to discovery
Conference Report: Advances in clinical analysis 2012
Managing scientific, technical and regulatory innovation in regulated bioanalysis: a discussion paper from the European Bioanalysis Forum
Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC–MS/MS
Preclinical bridging studies: understanding dried blood spot and plasma exposure profiles
Enantioselective analysis of ranolazine and desmethyl ranolazine in microsomal medium using dispersive liquid–liquid microextraction and LC–MS/MS
Ex vivo conversion of prodrug prothionamide to its metabolite prothionamide sulfoxide with different extraction techniques and their estimation in human plasma by LC–MS/MS
Bioanalytical assay strategies for the development of antibody–drug conjugate biotherapeutics
Characterization of critical reagents in ligand-binding assays: enabling robust bioanalytical methods and lifecycle management
Recent developments in emerging microimmunoassays
Acknowledgements